ElectromedELMD
ELMD
About: Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Employees: 174
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
967% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 3
179% more call options, than puts
Call options by funds: $801K | Put options by funds: $287K
78% more capital invested
Capital invested by funds: $52.8M [Q3] → $94M (+$41.2M) [Q4]
55% more funds holding
Funds holding: 53 [Q3] → 82 (+29) [Q4]
26% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 19
9.11% more ownership
Funds ownership: 28.48% [Q3] → 37.59% (+9.11%) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$38
36%
upside
Avg. target
$38
36%
upside
High target
$38
36%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
B. Riley Securities Kyle Bauser 75% 1-year accuracy 3 / 4 met price target | 36%upside $38 | Buy Initiated | 20 Feb 2025 |
Financial journalist opinion
Based on 3 articles about ELMD published over the past 30 days
Neutral
Seeking Alpha
1 week ago
Electromed, Inc. (ELMD) Q2 2025 Earnings Call Transcript
Electromed, Inc. (NYSE:ELMD ) Q2 2025 Earnings Conference Call February 11, 2025 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Good afternoon, and welcome to the Electromed Second Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.
Neutral
Business Wire
1 week ago
Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2024 (“Q2 FY 2025”). Q2 FY 2025 Company Highlights Net revenue increased 18.7% to a record $16.3 million in Q2 FY 2025, from $13.7 million in the second quarter of the prior fiscal year. Operating income increased to a record $2.5 million, 15.6% of net re.
Neutral
Business Wire
3 weeks ago
Electromed, Inc. Schedules its Second Quarter Fiscal 2025 Financial Results Conference Call for February 11, 2025 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 second quarter ended December 31, 2024, on February 11, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826.
Neutral
Seeking Alpha
3 months ago
Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript
Electromed, Inc. (NYSE:ELMD ) Q1 2025 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Hello, and welcome to the Electromed First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.
Positive
InvestorPlace
3 months ago
The Stocks Our Experts Are Trading Now
Why momentum trumps fear
Neutral
Business Wire
3 months ago
Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 (“Q1 FY 2025”). Q1 FY 2025 Financial Highlights Net revenue increased 19.0% to $14.7 million in Q1 FY 2025, from $12.3 million in the first quarter of the prior fiscal year. Gross margin was 78.3% of net revenues, compared to 77.1% in the first quarter of the prior fiscal y.
Neutral
Business Wire
3 months ago
Electromed, Inc. Schedules its First Quarter Fiscal 2025 Financial Results Conference Call for November 12, 2024 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 first quarter ended September 30, 2024, on November 12, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826.
Neutral
Business Wire
3 months ago
Electromed, Inc., Appoints Peter Horwich, Vice President, Marketing
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Peter Horwich as Vice President, Marketing. Mr. Horwich, an accomplished marketing veteran, brings over 20 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Horwich directed Global Strategic Marketing for Respiratory Therapies at Abiomed (now.
Positive
GuruFocus
4 months ago
Electromed Inc (ELMD) Trading 3.92% Higher on Oct 2
Shares of Electromed Inc (ELMD, Financial) surged 3.92% in mid-day trading on Oct 2. The stock reached an intraday high of $22.23, before settling at $21.72, up from its previous close of $20.90.
Neutral
Business Wire
5 months ago
Electromed, Inc. Announces Share Repurchase Authorization
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The new authorization follows the exhaustion of Electromed's previous share repurchase authorization in the fourth quarter of fiscal 2024, as previously reported. The timing and amount of share repu.
Charts implemented using Lightweight Charts™